ATC

Clinical trials for ATC explained in plain language.

Never miss a new study

Get alerted when new ATC trials appear

Sign up with your email to follow new studies for ATC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug tested for Tough-to-Treat cancers

Disease control Completed

This study tested a new drug, CFT1946, for people with advanced solid tumors that have a specific genetic change called BRAF V600. The main goals were to find a safe dose and see if the drug, given alone or with other medications, could help control the cancer. It involved 89 adu…

Matched conditions: ATC

Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

ATC

Get alerted when new ATC trials appear

New drug tested for Tough-to-Treat cancers